The edition · Paediatrics
Kawasaki aneurysms tracked with late IVIG, IVIG resistance and age under six months
A 40-year Italian cohort of 533 children found coronary aneurysms, though uncommon, caused every persistent coronary abnormality, and IVIG after day 10 raised the odds five-fold. Also: gaps in paediatric FH care, outcomes of eating-disorder stabilisation admissions, virtual reality before chemotherapy, and dichloroacetate for PDC deficiency.
The edition in brief
Among 533 children treated for Kawasaki disease at an Italian referral centre since 1982, 22% had acute coronary involvement but only 27 developed aneurysms, and persistent abnormalities occurred only with medium or giant aneurysms. Aneurysm was independently associated with IVIG resistance (OR 9.89), age under six months (OR 7.64), IVIG after day 10 (OR 5.27) and pericardial effusion (OR 3.16). Early recognition, especially of incomplete disease in young infants, and prompt escalation are the modifiable steps. The Australian FH registry of 341 children found diagnosis at a mean age of 11.9, genetic testing in half, LDL goals met in 48% and lipoprotein(a) measured in a third. Two UK hospitals' data on 85 young people admitted for medical stabilisation of restrictive eating disorders showed a median 21-day stay, refeeding syndrome in 24% and nasogastric feeding in 30%. A Hong Kong trial in 128 children aged 6 to 12 found immersive virtual reality before first chemotherapy reduced anxiety with large effect sizes and cut anticipatory nausea and vomiting. A phase III crossover trial of dichloroacetate in 34 children with PDC deficiency missed its primary motor end point, with signals only in the open-label extension.
Children with FH are diagnosed late and undertreated
Test the children of parents with FH early, and add ezetimibe when a statin alone does not reach the LDL target.
Paediatric ward stabilisation for restrictive eating disorders
Expect refeeding syndrome in about one in four eating-disorder stabilisation admissions and monitor electrolytes daily at first.
Virtual reality before first chemotherapy reduced anxiety and nausea
Add immersive virtual reality to antiemetic care for children starting chemotherapy to reduce anxiety and anticipatory nausea.
Dichloroacetate for PDC deficiency missed its primary end point
Dichloroacetate for PDC deficiency remains unproven; the randomised comparison was negative.
Think Kawasaki in the febrile infant who does not fit
In a young infant with five days of unexplained fever and high inflammatory markers, get an echocardiogram and consider incomplete Kawasaki.
Kawasaki: late IVIG and resistance predict the aneurysms that persist
Treat Kawasaki disease with IVIG before day 10 and escalate promptly on IVIG resistance, especially in infants under six months.
Read the rest in the app
You have read your two free briefings this month. The app carries all 27 specialties, every morning, free — and this one is waiting in it.

Scan to keep reading on your phone. No account needed to start.
Tomorrow morning, before your first patient
One edition a day for paediatrics, written by the desk, every claim tied to its paper. Six minutes.
Get the app — free